Evidence map›Paper›PMID 32931555›Full record

ArticlePhysical therapy2020

Integrating Symptoms Into the Diagnostic Criteria for Breast Cancer-Related Lymphedema: Applying Results From a Prospective Surveillance Program.

Cheryl L Brunelle, Sacha A Roberts, Nora K Horick, Tessa C Gillespie, Jamie M Jacobs, Kayla M Daniell, George E Naoum, Alphonse G Taghian

Open access · bronzeAbstract read
In one paragraph

Article in Physical therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. The impact of lymphedema severity on shoulder joint function and muscle activation patterns in breast cancer survivors: a cross-sectional study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Observational
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Cheryl L BrunelleDepartment of Physical and Occupational Therapy, Massachusetts General Hospital, Boston, Massachusetts.
Sacha A RobertsDepartment of Radiation Oncology, Massachusetts General Hospital.
Nora K HorickBiostatistics Center, Massachusetts General Hospital.
Tessa C GillespieDepartment of Radiation Oncology, Massachusetts General Hospital.
Jamie M JacobsCenter for Psychiatric Oncology and Behavioral Sciences, Massachusetts General Hospital.
Kayla M DaniellDepartment of Radiation Oncology, Massachusetts General Hospital.
George E NaoumDepartment of Radiation Oncology, Massachusetts General Hospital.
Alphonse G TaghianDepartment of Radiation Oncology, Massachusetts General Hospital, 55 Fruit St, Boston, MA 02114 (USA).
Massachusetts General Hospital · US

Funding

Early Detection and Treatment of Lymphedema in Women with Breast CancerR01CA139118 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI TAGHIAN, ALPHONSE G · 2009 to 2013
$1.4M
NCI NIH HHS R01 CA139118
6 · The paper itself

Abstract

objectiveThe objectives of this study were to determine whether patients reporting symptoms are more likely to develop lymphedema and to describe the temporal relationship between symptom onset and lymphedema.

methodsThis was a prospective longitudinal cohort study of 647 women treated for breast cancer and screened for lymphedema using arm volume measurements and subjective questionnaires (n = 647; 2284 questionnaires [median 3.5 per patient, range = 1-24]). Primary study outcome was lymphedema (relative volume change ≥10%). The Kaplan-Meier method was used to estimate cumulative lymphedema incidence. Cox proportional hazards models were used to assess the relationship between symptoms, other risk factors, and lymphedema.

resultsA total of 64 patients (9.9%) developed lymphedema. On multivariable analysis, patients reporting increased arm size (hazard ratio = 3.09, 95% CI = 1.62-5.89) were more likely to progress to lymphedema than those who did not report this symptom. Of those who developed lymphedema, 37 (58%) reported an increased arm size a median of 6.1 months before lymphedema onset (range = 68.6 months before to 50.2 months after lymphedema onset).

conclusionPatients at risk of lymphedema who report increased arm size might do so prior to lymphedema onset and are at 3 times the risk of lymphedema as patients not reporting this symptom. Even without objective or observable edema, these patients should be followed vigilantly and considered for early intervention. Symptoms should be incorporated into screening and diagnostic criteria for lymphedema. IMPACT: This study shows that patients at risk for breast cancer-related lymphedema who report increased arm size should be considered at high risk for progression to lymphedema-even without edema on measurement or clinical examination-and should be followed vigilantly, with consideration of early intervention. LAY SUMMARY: If you are at risk of lymphedema and you feel as though your arm size has increased, you might develop lymphedema, and you are at 3 times the risk of lymphedema as patients not reporting this symptom. Even without measurable or observable edema, you should be followed vigilantly and consider early intervention.

Indexed as

AdultAgedAged, 80 and overArmBreast NeoplasmsDisease ProgressionEpidemiologic StudiesFemaleHealth SurveysHumansLymphedemaMiddle AgedOrgan SizePostoperative ComplicationsRisk FactorsSymptom Assessment

Identifiers

PMID32931555
PMCPMC7824870
OpenAlexW3087472121

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.